StockData
Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc (JAZZ) stock

JAZZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 7/30122% above fair value
$240.71+0.94 (+0.39%)

Close on Nov 17, 2026Market cap $15.63BP/E 78.4Yield –

Jazz Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Jazz Pharmaceuticals's price to book ratio was 3.3× on Nov 11, 2026, against 2.7× a year earlier. Over the last 5 years it ranged from 1.6× to 3.6×, with a median of 2.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.3×+0.7
2025Dec 31, 20252.6×+0.7
2024Dec 31, 20242.0×−0.5
2023Dec 29, 20232.5×−1.2
2022Dec 30, 20223.6×+1.7
2021Dec 31, 20211.9×−0.8
2020Dec 31, 20202.8×−0.1
2019Dec 31, 20192.9×+0.3
2018Dec 31, 20182.5×−0.8
2017Dec 29, 20173.3×−0.4
2016Dec 30, 20163.7×−2.2
2015Dec 31, 20155.9×−1.6
2014Dec 31, 20147.5×+1.2
2013Dec 31, 20136.3×+2.8
2012Dec 31, 20123.4×−9.1
2011Dec 30, 201112.5×–

More Jazz Pharmaceuticals figures

See a number that looks wrong?